Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks

来自热带海洋软体动物细菌共生体的多种药物先导化合物

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Philippine Mollusk Symbiont ICBG (PMS ICBG) project links a biodiversity survey of marine mollusks in one of the world's hotspots of diversity, with drug discovery and enzyme bioprospecting aimed at bacterial symbionts of mollusks. Mollusks constitute the most diverse marine eukaryotic group, occupying virtually every possible ecological niche. The diversity of microbes associated with mollusks is equally vast. Within the mollusks, three particular groups exhibit what we believe to be the highest biotechnological and scientific potential: the bivalve family Teredinidae (genus Teredo) and the gastropod superfamilies Conoidea (genus Conus) and Muricoidea (genus Murex). The project directly addresses the goals of the ICBG program and will yield drug leads in central nervous system, cancer and antimicrobial areas, as well as strains and enzymes for cellulosic biofuels production. The project will characterize symbiotic diversity and pharmaceutical and biofuels potential of mollusk-associated bacteria in a comparative framework for the first time. The plan focuses on training, conservation, and the development of drug discovery and biofuels programs within the Philippines. The Republic of the Philippines represents a unique nexus of exceptional biodiversity, dense human population with pressing societal and energy needs, consequent urgent conservation goals, and government and private sector commitment to education and technology to harness national human and natural resources for a sustainable future The project is led by Margo Haygood, marine microbiologist, Oregon Heath & Science University, in association with Gisela Concepcion, marine natural products chemist, University of the Philippines, Baldomero Olivera, biochemist, and Eric Schmidt, natural products chemist and biochemist, both of University of Utah, Gary Rosenberg, evolutionary biologist, Academy of Natural Sciences, Philadelphia, and Daniel Distel, marine microbiologist, Ocean Genome Legacy.
描述(由申请人提供):菲律宾软体动物共生体ICBG(PMS ICBG)项目将世界上最具多样性的热点之一的海洋软体动物生物多样性调查与针对软体动物细菌共生体的药物发现和酶生物勘探联系起来。软体动物构成了最多样化的海洋真核生物群体,几乎占据了所有可能的生态位。与软体动物相关的微生物的多样性也同样巨大。在软体动物中,有三个特殊的类群展示了我们认为最高的生物技术和科学潜力:双壳类家族Teredinidae(Teredo属)和腹足类超家族Conoidae(Conus属)和Muricoidae(Murex属)。该项目直接实现了ICBG计划的目标,并将在中枢神经系统、癌症和抗菌领域产生药物先导,以及用于生产纤维素生物燃料的菌株和酶。该项目将首次在比较框架内表征软体动物相关细菌的共生多样性以及制药和生物燃料潜力。该计划的重点是菲律宾境内的培训、保护以及药物发现和生物燃料项目的发展。菲律宾共和国是一个独特的联系:异常的生物多样性,人口稠密,迫切的社会和能源需求,随之而来的紧迫的保护目标,以及政府和私营部门对教育和技术的承诺,以利用国家的人类和自然资源,以实现可持续的未来该项目由俄勒冈卫生与科学大学海洋微生物学家Margo Haygood和菲律宾大学海洋天然产品化学家Gisela Concepcion,菲律宾大学海洋天然产品化学家Baldomero Olivera和犹他州大学自然科学院进化生物学家Gary Rosenberg和海洋基因组海洋微生物学家Daniel Distel共同领导。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margo Genevieve Haygood其他文献

Margo Genevieve Haygood的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margo Genevieve Haygood', 18)}}的其他基金

Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks
来自热带海洋软体动物细菌共生体的多种药物先导化合物
  • 批准号:
    7908314
  • 财政年份:
    2009
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks
来自热带海洋软体动物细菌共生体的多种药物先导化合物
  • 批准号:
    8287156
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse Drug Lead Compounds from Bacterial Symbionts in Philippine Mollusks
菲律宾软体动物细菌共生体中的多种药物先导化合物
  • 批准号:
    9127839
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks
来自热带海洋软体动物细菌共生体的多种药物先导化合物
  • 批准号:
    7688593
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks
来自热带海洋软体动物细菌共生体的多种药物先导化合物
  • 批准号:
    8109977
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse Drug Lead Compounds from Bacterial Symbionts in Philippine Mollusks
菲律宾软体动物细菌共生体中的多种药物先导化合物
  • 批准号:
    8783901
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks
来自热带海洋软体动物细菌共生体的多种药物先导化合物
  • 批准号:
    8693423
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse Drug Lead Compounds from Bacterial Symbionts in Philippine Mollusks
菲律宾软体动物细菌共生体中的多种药物先导化合物
  • 批准号:
    9132381
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse drug lead compounds from bacterial symbionts in tropical marine mollusks
来自热带海洋软体动物细菌共生体的多种药物先导化合物
  • 批准号:
    7885465
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:
Diverse Drug Lead Compounds from Bacterial Symbionts in Philippine Mollusks
菲律宾软体动物细菌共生体中的多种药物先导化合物
  • 批准号:
    8918043
  • 财政年份:
    2008
  • 资助金额:
    $ 65.7万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 65.7万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了